HHS Secretary Azar says ‘need to see more’ drug price ‘good behavior’

Secretary of the U.S. Department of Health & Human Services Alex Azar tweeted: “We’ve seen some good behavior from companies such as Merck, Gilead, and Amgen, who announced lower prices for their drugs. We need to see more. @POTUS and I won’t stop until American patients see the lower prices they deserve.” Azar called out Merck (MRK), Gilead (GILD) and Amgen (AMGN) by name in his tweet. Other publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY)
https://thefly.com/landingPageNews.php?id=2846307